AS
ALXN

Altshuler Shaham’s Alexion Pharmaceuticals ALXN Stock Holding History

Altshuler Shaham’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-306
Closed -$48K – 560
2020
Q4 		$48K Buy
+306
New +$39.3K ﹤0.01% 270
2020
Q2 		– Sell
-3
Closed – – 627
2020
Q1 		$0 Hold
3
– – ﹤0.01% 652
2019
Q4 		$0 Hold
3
– – ﹤0.01% 658
2019
Q3 		$0 Buy
+3
New +$338 ﹤0.01% 594

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's ALXN Position: Q1 2021 in Review

Altshuler Shaham sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 306 shares — an estimated $48K sold.

Altshuler Shaham first reported a position in ALXN in Q3 2019 and held it in 4 quarters. The position peaked at $48K in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Altshuler Shaham reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Altshuler Shaham sold 306 Alexion Pharmaceuticals shares in Q1 2021, an estimated $48K.
  • Altshuler Shaham first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Altshuler Shaham's Alexion Pharmaceuticals position peaked at $48K in Q4 2020.
  • 754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.